Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD1d is a non-polymorphic MHC class I-like molecule that presents lipid and glycolipid antigens to iNKT cells. This interaction triggers iNKT cell activation, leading to the release of cytokines and cytotoxic activity, influencing both innate and adaptive immunity. CD1d plays a crucial role in various diseases, including asthma, cancer, infectious diseases, and autoimmune disorders, making it a potential therapeutic target.
Agonist of iNKT cell receptor via CD1d presentation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD1d molecule (CD1d).